Follow the Manufacturers: Who Really Makes Store-Brand Dog Supplements
Our Investigations Desk —
On this page
Key Takeaways
- The pet supplement industry relies heavily on a small number of contract manufacturers and co-packers, meaning many “brands” share production lines, formulations, or even finished products.
- White-label and private-label business models dominate chews and soft chews, and most consumer-facing brands disclose almost nothing about who actually makes their products.
- Manufacturing concentration creates real risks: a single supplier issue, recall, or reformulation can affect dozens of brands simultaneously.
- We propose a four-criterion sourcing transparency score (factory disclosure, NASC/NFS certification, country of manufacture, and lot-level traceability) that consumers can apply to any label.
- Independent testing and clinical evidence remain the strongest differentiators when the factory behind multiple brands is identical.
Walk down the supplement aisle of any pet retailer — physical or online — and you will see a wall of brand names. Calming chews, probiotic sticks, joint soft chews, skin and coat formulas, each with its own packaging, color story, and marketing angle. Most consumers assume these are made by separate companies, perhaps even in separate factories. The reality is more complicated, and arguably more important to understand, than the strain-count arms race or the CFU stability problem we have documented in earlier investigations.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
The Contract Manufacturing Reality Behind the Brand Wall
The pet supplement industry has, over the last decade, consolidated around a handful of full-service contract manufacturers (often called co-packers or third-party manufacturers) that produce finished products for dozens or even hundreds of brands. A brand may design its label, write its copy, select flavors, and place orders — but the actual blending, encapsulation, chew-forming, bottling, and quality control happen inside a facility it does not own.
This is not inherently deceptive. Contract manufacturing is the standard operating model across supplements for humans and animals alike. The problem is one of disclosure asymmetry: brands market their products as if they were formulated, tested, and controlled end-to-end, when in reality they are purchasing a base formulation from a manufacturer catalog and applying their own label.
For veterinarians and informed consumers, the practical consequences are threefold:
- Formulation similarity. Brands that buy from the same co-packer often start with the same base formula. Differentiation then comes from flavor, color, packaging, and marketing claims — not from any meaningful change in active ingredient composition.
- Shared supply chain risk. A raw material contamination event, a packaging defect, or a regulatory action at one large manufacturer can cascade across many seemingly distinct brands.
- Evidence gaps. When a base formula is sold white-label, no single brand owns the incentive to fund clinical trials on it. The result is an industry where nearly every product’s efficacy rests on ingredient-level research, not on the specific finished product in the tub.
White Label, Private Label, and Co-Packing — What’s the Difference?
These three terms are often used interchangeably, but the distinctions matter:
- White label: The manufacturer produces a generic finished product and sells it to multiple retailers or brands who then apply their own labels. The underlying product is identical across buyers.
- Private label: A buyer (often a retailer) commissions a manufacturer to produce a product to their own specifications, but the manufacturer still does the production. Specifications may be modest variations on stock formulas.
- Co-packing: A broader term covering any contract production relationship, including brands with their own R&D that outsource manufacturing for capacity reasons.
The first two models dominate the pet supplement soft-chew and powder space. The third is more common among brands that genuinely develop proprietary formulations — though proprietary development and contract production are not mutually exclusive.
Where the Disclosure Vacuum Lives
The FDA requires pet food and supplement manufacturers to disclose the name and address of the producer on the label (the “manufactured by” or “distributed by” statement), but that single line is typically all consumers get. There is no requirement to disclose:
- The full ingredient supplier list (beyond what is on the ingredient panel)
- Whether the product was made at a shared facility with other brands
- The country of origin for individual active ingredients
- Whether the formulation was purchased from a third-party catalog or developed in-house
As we have noted in our ongoing investigation of review-site economics and marketing logic, the supplement space rewards confident claims over transparent disclosure. Manufacturing origin is no exception.
The Concentration Problem: Why Three Factories Matter
Industry trade data — including supplier directories from the National Animal Supplement Council (NASC) and pet industry trade publications — point to a relatively concentrated manufacturing base for finished soft chews and oral powders. A small number of mid-to-large contract manufacturers in the United States produce the majority of pet supplement chews sold under different brand names.
What Concentration Means for Consumers
Concentration is not, by itself, evidence of anything wrong. Large established manufacturers can have rigorous quality systems. But concentration does change the risk calculus in specific ways:
- Single point of failure. When three factories make most of the chews, a production disruption at any one of them removes a significant share of the market’s supply simultaneously.
- Uniform quality variation. If a base formula has a subtle issue — stability, bioavailability, palatability — it appears under many brand names at once, with no brand having the data to identify the pattern because each sees only its own lots.
- Margin pressure on real differentiation. When white-label catalogs make it cheap to launch a new brand, genuinely invested brands (with in-house R&D, clinical trials, and full disclosure) compete on price and packaging against products that did not bear those costs.
For veterinarians and pet owners, the practical takeaway is that brand identity in pet supplements is a much weaker proxy for product identity than the marketing implies.
A Sourcing Transparency Scoring Rubric
If brand identity is a weak signal, consumers need a different lens. We propose a simple four-criterion rubric that any pet owner can apply to any pet supplement label, regardless of brand. Each criterion scores one point, for a maximum transparency score of four.
Criterion 1: Factory Disclosure
Does the brand name its contract manufacturer (or identify itself as the manufacturer) somewhere outside the fine-print “manufactured by” line? Many reputable brands include this information on their website, in their FAQ, or in a “our process” page. Brands that obscure this score zero. Brands that name the co-packer — and ideally describe the relationship — score one.
Criterion 2: Certification Status
Does the product carry an NASC Quality Seal, or is the manufacturer certified to a recognized standard such as NSF/ANSI 173 (dietary supplements) or cGMP? The NASC seal is widely held in the industry and indicates compliance with the council’s quality program — it is a positive signal but not a guarantee of efficacy. Absence of any third-party certification scores zero. Presence of at least one recognized certification scores one.
Criterion 3: Country and Region of Manufacture
Is the country of final manufacture clearly disclosed beyond the legal minimum? “Made in the USA from globally sourced ingredients” is a meaningful disclosure (and is required by FTC for that claim). Vague or absent origin information scores zero. Clear country-of-final-manufacture disclosure plus any additional ingredient origin detail scores one.
Criterion 4: Lot-Level Traceability
Does the brand publish lot numbers, expiration dates, and a process for trace-back in the event of a quality concern? Every legitimate supplement has lot numbers on the bottle — but publishing what the brand does with that data, and making it accessible, is the meaningful test. Most brands score zero. Brands that explicitly describe their traceability process — including how they handle consumer reports of adverse events — score one.
| Brand / Product | Factory Disclosure | Certification | Origin Clarity | Lot Traceability | Transparency Score (of 4) |
|---|---|---|---|---|---|
| Generic Store-Brand Chew (illustrative) | 0 | 0–1 | 0 | 0 | 0–1 |
| Mid-Tier DTC Brand (illustrative) | 0–1 | 1 | 1 | 0 | 2–3 |
| Established Clinical Brand (illustrative) | 1 | 1 | 1 | 1 | 4 |
Scores represent editorial assessment based on publicly available packaging and web disclosures at time of review. No lab testing was performed. Categories are illustrative; specific brand scores will vary.
When Manufacturing Transparency Is Not Enough: The Evidence Question
Sourcing transparency is necessary but not sufficient. Even a fully disclosed supply chain tells you nothing about whether the finished product works. Two products made in the same factory with identical ingredient panels can be sold by brands making wildly different efficacy claims — and the consumer has no way to verify the claim except by looking for independent evidence.
As we have documented in our investigation of high-CFU probiotic chews and our review of allergy claims, the gap between label claims and published evidence is wide across the category. Manufacturing transparency narrows one part of that gap. Published, peer-reviewed clinical trials on the specific finished product narrow the rest.
When you combine the two — a brand that names its factory, holds recognized certifications, discloses origin clearly, and funds independent trials on its own finished product — you are looking at a genuinely different category of brand than the white-label catalog buyer. Most brands in the pet supplement space do not currently meet this bar. The ones that do deserve explicit recognition.
Frequently Asked Questions
What is a contract manufacturer in pet supplements?
A contract manufacturer (also called a co-packer) produces finished pet supplement products on behalf of brands that sell them under their own labels. The brand handles marketing and distribution; the manufacturer handles formulation production, quality control, and packaging. Many pet supplement brands rely entirely on contract manufacturers rather than operating their own production facilities.
How can I find out who actually makes a pet supplement?
Start with the label’s “manufactured by” or “distributed by” line, which is legally required. Then check the brand’s website for a manufacturing or quality page; some brands publish their co-packer relationship explicitly. If neither the label nor the website discloses the manufacturer, that is itself a signal — and our transparency rubric would score that brand zero on factory disclosure.
Does the NASC seal guarantee a product works?
No. The NASC Quality Seal indicates that the manufacturer has met the council’s quality program requirements, including adverse-event reporting, label compliance, and GMP-level manufacturing standards. It is a meaningful quality signal, but it is not an efficacy certification. A product can carry the NASC seal and still lack clinical evidence for its specific health claims.
Are co-manufactured products lower quality than brand-owned products?
Not necessarily. Quality depends on the specific manufacturer’s systems, the brand’s specifications, and the level of oversight the brand exercises — not on ownership of the factory itself. Many excellent products are co-manufactured. The concern is not co-manufacturing per se, but the lack of disclosure and the way white-label catalogs enable brands to market commodity formulas as differentiated products.
References
- Plaignier M, et al. Effects of a postbiotic and prebiotic oral health supplement on dental plaque and gingival health in dogs. American Journal of Veterinary Research. 2026. PMID: 40509062.
- Schmidt V, et al. Gut-skin axis modulation with a postbiotic-prebiotic combination in canine atopic dermatitis: a randomized controlled trial. Veterinary Dermatology. 2026. PMID: 40723482.
- National Animal Supplement Council. NASC Quality Seal Program Overview. nacp.nasc.org.
- NSF International. NSF/ANSI 173 Standard for Dietary Supplements. nsf.org.
- U.S. Food and Drug Administration. 21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
